Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare Biotechnology
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd
Bullboard Posts
User Avatar Image
(41)
•••
Comment by JAKPUG4LIFEon Oct 16, 2020 10:00am
132 Views
Post# 31727589

RE:RE:Coming another 9.5M dilution!

RE:RE:Coming another 9.5M dilution!Another big drop this am, closing in on a penny. I'm in
Bigmac4000 wrote: The only way they can sell these shares is way below market value so these "investors" can get out easily with some gains. The stock last year at this time was 7.7 million shares and now is over 18 million shares. In a year they are working towards tripling shares. They offered another 10 million dollars worth to the original investors. That will put FSD over 22 million shares or triple the RS amount in a year. Someone has to start a class action lawsuit. I'm in. The pyramid scheme is still going. Wait till they RS in 2021. Let's see the excuses then. I'm shocked Nasdaq is allowing this. When this gets delisted its going to make a movie for sure. From the dream penny stock in 2018 to dead in the water in 2021 with hundreds of millions squandered. This will make the wolf on wallstreet look like a children's movie
Paray99 wrote: Looks like they are getting another 10M into their pockets before releasing any ear soothing results from the clinical trial evaluation. To me it is their last pay before bearing investors to the ground!




Bullboard Posts
Dealroom for high-potential pre-IPO opportunities